[Interstitial lung disease due to domestic moulds]

A-L Blanc1, L Delhaes, M-C Copin

  • 1Service de pneumologie et immunoallergologie, centre de compétence des maladies pulmonaires rares, CHRU hôpital Calmette, boulevard du Pr-J.-Leclercq, 59037 Lille cedex, France.

Insights

A patient with interstitial pneumonia improved after moving homes, suggesting a link to domestic mold exposure, specifically Stachybotrys chartarum. This highlights the importance of investigating environmental mycotoxins in lung disease.

Area of Science:

  • Pulmonology
  • Environmental Medicine
  • Mycology

Background:

  • Interstitial pneumonia diagnosis can be challenging, particularly when environmental factors are implicated.
  • Fungal exposure in domestic environments is increasingly recognized as a potential contributor to lung disease.

Observation:

  • A 53-year-old patient presented with severe hypoxemia and diffuse ground glass opacities on CT, unresponsive to initial treatments.
  • Bronchoscopy revealed white deposits, and lavage showed lymphocytosis; mold serology indicated a reaction to Stachybotrys chartarum.
  • Lung biopsy confirmed bronchiolocentric interstitial pneumonia.

Findings:

  • The patient's condition significantly improved, with normalization of clinical, radiological, and functional parameters, after relocating to a new residence.
  • The final diagnosis was interstitial lung disease secondary to mycotoxins produced by Stachybotrys chartarum.
  • Pulmonary function tests indicated a moderate restrictive pattern with impaired carbon monoxide diffusion.

Implications:

  • Hypersensitivity pneumonitis or mycotoxin-induced interstitial lung disease should be considered in patients with unexplained interstitial pneumonia.
  • Specific environmental investigations are crucial for identifying mold-related allergens or toxins contributing to lung pathology.
  • Prompt identification and removal of the environmental trigger can lead to significant clinical improvement.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...